-
U.S. artillery setbacks open door for Korea's K9
SEOUL, August 24 (AJP) - U.S. artillery helped South Korea withstand North Korea's invasion in the Korean War. More than seven decades later, the U.S. Army is testing a South Korean gun to help modernize its own firepower.
-
Ruling Adilet sweeps first vote for new Kazakh parliament
Almaty, August 24 (AJP) -Kazakhstan's ruling Adilet party swept to a landslide victory with 71.17 percent of the vote in preliminary results from Sunday's parliamentary election, far ahead of its rivals in the country's first vote for the new single-chamber Kurultai.
-
BOK August rate call splits 5-4 over back-to-back hike
SEOUL, August 24 (AJP) - The Bank of Korea has made clear that monetary policy is biased toward further tightening after its July rate increase, but economists are narrowly divided over whether it will deliver a back-to-back hike this week or wait until the fourth quarter.
-
Taiwan drone defense gaps emerge as US-Korea drills scale back
SEOUL, August 24 (AJP) - As the United States and South Korea scaled back their largest summertime military exercise, defense experts in Taiwan were highlighting gaps exposed by their own drills, calling for stronger layered air defenses against drones and other low-altitude threats.
-
Korea's 5-year bond auction split raises demand concerns
SEOUL, August 24 (AJP) - South Korea's new five-year government bond auction produced a wide range of accepted yields on Monday, signaling uneven investor pricing and trimming an earlier rally in the local bond market despite a strong headline bid ratio.
-
Hanmi Pharm signs massive licensing deal with US biotech firm for obesity drug
SEOUL, August 24 (AJP) - Hanmi Pharm said Monday it has signed an exclusive licensing agreement with U.S. biotechnology company Genentech, a subsidiary of Swiss healthcare company Roche, to develop and commercialize its obesity drug candidate HM17321 worldwide.
-
Celltrion files for approval of Keytruda biosimilar
SEOUL, August 24 (AJP) - Celltrion announced it has applied to South Korea's drug regulator for approval of CT-P51, a biosimilar version of Merck's blockbuster cancer drug Keytruda, joining a race among Korean drugmakers to grab market share once the original loses patent protection.
-
HD Hyundai affiliate wins major order for LPG carriers
SEOUL, August 24 (AJP) - HD Korea Shipbuilding & Offshore Engineering has won a contract from an Oceania-based shipping company to build four liquefied petroleum gas (LPG) carriers, it said on Monday.
-
Samsung forecast to reclaim No. 1 spot in global smartphone shipments
SEOUL, August 24 (AJP) - Samsung Electronics is expected to reclaim the top spot in the global smartphone market this year as its shipments rise while those of archrival Apple decline, according to a report released by Counterpoint Research on Monday.
-
Samsung buyback disappointment pushes KOSPI down 3.1%
SEOUL, August 24 (AJP) - South Korea's benchmark KOSPI plunged 3.1 percent Monday as Samsung Electronics' record shareholder-return plan disappointed investors, triggering heavy selling in large-cap technology stocks even as the broader KOSDAQ market rose. The KOSPI shed 215.99 points to 6,696.96. Foreign investors sold a net 3.68 trillion won ($2.66 billion) and institutions sold 1.29 trillion won ($936 million), while individuals bought 3.32 trillion won ($2.40 billion). Samsung Ele
-
Won hits 11-month high, Korean bonds rally as stocks tumble
SEOUL, August 24 (AJP) - The South Korean won strengthened to an 11-month high against the dollar on Monday. Government bonds also rallied as stocks tumbled and foreign investors bought bond futures. The won strengthened 4.1 won from the previous session to close daytime trading at 1,382.4 per dollar, compared with Friday's 1,386.5. The currency briefly strengthened to 1,376.5 during the session and extended its advance for a seventh straight trading day, the longest such streak since Dece
-
H.PIO stock bolstered by stock retire scheme
SEOUL, August 24 (AJP) -South Korean health supplement maker H.PIO's shares rose Monday after the company announced plans to cancel all of its treasury shares. Its shares closed 2.64 percent higher at 2,135 won ($1.54) on the KOSDAQ. The KOSDAQ-listed company said its board approved the cancellation of 191,003 common shares, according to a regulatory filing Monday. The cancellation is scheduled for Sept. 11. The cancellation represents about 0.46 percent of its 41.29 million outstanding co
-
Chip equipment maker rides surprise rally in tandem with Moderna's triple-digit surge
SEOUL, August 20 (AJP) - Shares of semiconductor equipment maker N2TECH hit their daily limit on Thursday as investors rushed into related South Korean stocks following Moderna's positive results from a late-stage cancer vaccine clinical trial. N2TECH's shares closed at 1,925 won on the junior KOSDAQ, up 29.98 percent from the previous session. The stock opened at 1,831 won and fell as low as 1,646 won before rebounding to the daily limit. The rally came after U.S. biotech firm Moderna
-
How Seoul's hillside neighborhood becomes hidden gem for foreigners
SEOUL, August 21 (AJP) - On a steep hillside beneath Mt. Namsan, a neighborhood once known for cheap housing is giving foreigners a reason to look beyond Seoul's better-known hotspots. It is not as crowded as Seoul's hip Hongik University neighborhood, a popular nightlife district known for its youthful energy or as busy as nearby Itaewon, Seoul's best-known international and entertainment district. Yet Haebangchon has plenty of bars, restaurants and cafés within walking dis
by Ryu Yuna
-
Viet Nam's Gen Z protests without gathering
SEOUL, August 21 (AJP) - The flowers under the tree outside No. 55 Nguyen Huy Tu Street arrived one at a time, which is why the police had nothing to break up. Over roughly a week in August, young Vietnamese walked to the spot in central Hanoi, left a bouquet, photographed it and went home. By the time the pile was large enough to be a problem, no crowd had ever formed. The tree marks the place where a car crossed into oncoming traffic on May 30, 2025, and struck a motorbike carrying a father a
by Park Sae-jin
-
Blizzard rules out Korea-only balance patches for Overwatch
BUSAN, August 23 (AJP) - Blizzard Entertainment will keep balancing Overwatch as a single global game rather than tailoring patches to Korea even under its new Nexon partnership, its game director said, even as Korean players keep pulling the shooter's meta in their own direction. "We typically don't try to balance the game differently per region," Aaron Keller said at a press conference at BEXCO, on the second and final day of Overwatch Day, the fan festival staged by Nexon.
-
In Busan, Overwatch stops visiting and moves in
BUSAN, August 22 (AJP) - A row of Overwatch's heroes had stepped off the screen onto a strip of astroturf — D.Va flashing her decorated pistol, Reaper looming under his hood, while Genji meditated on an orange beanbag, eyes shut tight in ease. All around the packed halls of BEXCO, thousands of fans of Blizzard's tactical shooter Overwatch buzzed with hype, clutching tote bags branded with the iconic circular pattern and the stamp-rally cards that would soon be creased from a full
-
Sovereign AI race pulls world deeper into Nvidia's orbit
SEOUL, August 24 (AJP) - When South Korea named the three teams last week that will carry its bid for a homegrown artificial intelligence model, the reward that mattered most was not cash or recognition. It was more Nvidia. The government said on Aug. 18 that SK Telecom, LG AI Research and startup Upstage had cleared the second round of its sovereign AI foundation model contest. For the next stage, each team will receive access to roughly 1,000 Nvidia B200 graphics processing units, up from ab
-
BigBang's 20th anniversary comes as older K-pop acts find new life
SEOUL, August 19 (AJP) - K-pop boy band BigBang marked their 20th anniversary on Wednesday with their first digital single in four years, hoping to continue attracting attention years after their heyday. Their return comes as older K-pop groups are gaining renewed attention, attracting both longtime fans and younger listeners discovering their music years after their debut. But another shift is unfolding at the same time. While veteran acts are finding ways to stay together, some younger idols